M&A Transactions

Scienture Holdings, Inc. completed an acquisition involving Superlatus, Inc. for 136,441 shares of common stock of the Company, representing 19.9% of the total issued and outstanding common stock of the Company after the consummation of the (closed 2023-07-31).

“the surviving entity in the Merger. Under the terms of the A&R Merger Agreement, at the closing of the Merger (the “Closing”), shareholders of Superlatus received in aggregate 136,441 shares of common stock of the Company, representing 19.9% of the total issued and outstanding common stock of the Company after the consummation of the Merger and 306,855 shares”

Innovex International, Inc. completed an acquisition involving Industrial Growth Partners V AIV L.P. for $105 million CAD (closed 2023-07-31).

“On July 31, 2023, TIW Canada ULC (“Purchaser”), an unlimited liability company governed by the Laws of Alberta and wholly-owned subsidiary of Dril-Quip, Inc. (“Dril-Quip”), acquired all of the issued and outstanding shares in the capital of 1185641 B.C. Ltd. (d/b/a Great North Wellhead and Frac), a corporation governed by the laws of the province of British Columbia (the “Company”), pursuant to a definitive agreement (the “Share Purchase Agreement”), dated as of July 31, 2023, among each of the shareholders of the Company (collectively, “Sellers”), Industrial Growth Partners V AIV L.P., in its capacity as agent to Sellers thereunder, Purchaser and, solely in its capacity as guarantor for the obligations of Purchaser thereunder, Dril-Quip for a cash purchase price of $105 million CAD.”

AEROJET ROCKETDYNE HOLDINGS, INC. underwent a change of control involving L3Harris Technologies, Inc. (closed 2023-07-28).

“On July 28, 2023, at the effective time of the Merger (the “Effective Time”), Merger Sub merged with and into Aerojet Rocketdyne (the “Merger”), and Aerojet Rocketdyne continued its existence under Delaware law as the surviving corporation in the Merger and a wholly owned subsidiary of L3Harris.”

L3HARRIS TECHNOLOGIES, INC. /DE/ completed an acquisition involving Aerojet Rocketdyne Holdings, Inc. for $58.00 in cash (closed 2023-07-28).

“wholly owned subsidiaries and (ii) with respect to which appraisal rights have been properly exercised and perfected) was canceled and converted into the right to receive $58.00 in cash, without interest (the “Merger Consideration”). At the Effective Time, each outstanding Aerojet Rocketdyne stock appreciation right automatically vested and was cancelled”

TPG Twin Brook Capital Income Fund completed an acquisition involving AG Twin Brook BDC, Inc. for approximately $193 million (closed 2023-07-28).

“interest (the “Per Share Consideration”), subject to any applicable withholding taxes. The Fund paid total cash consideration in connection with the Transaction of approximately $193 million (the “Total Consideration”). The Fund funded the Total Consideration for the Transaction with $180 million of borrowings under its credit facilities and $13 million of available”

Hempacco Co., Inc. completed an acquisition involving Viva Veritas LLC for $3,500,000 (closed 2023-07-24).

“which shares constitute 50% of Green Star’s outstanding stock, and (ii) the Seller’s bottling and gummy line inventory and equipment (the “ Assets ”), for total consideration of $3,500,000, with $300,000 paid in cash (which was deemed previously paid by the Company), and $3,200,000 paid by the issuance of a convertible promissory note to the Seller (the “ Note ”).”

GreenLight Biosciences Holdings, PBC underwent a change of control involving SW ParentCo, Inc. for approximately $9.3 million (closed 2023-07-24).

“On July 24, 2023, the Offer and the Merger were completed as described under “Introductory Note.” The aggregate consideration paid by Merger Sub in the Offer and the Merger to purchase all outstanding shares of Company Common Stock (other than the Rollover Shares), was approximately $9.3 million.”

AG Twin Brook BDC, Inc. underwent a change of control involving AG Twin Brook Capital Income Fund for $20 per share in cash (closed 2023-07-28).

“of common stock, par value $0.001 per share, of the Company (the “Common Stock”) outstanding immediately prior to the Effective Time was converted into the right to receive $20 per share in cash, without interest (the “Per Share Consideration”), subject to any applicable withholding taxes. TCAP paid total cash consideration in connection with the”

NEW ROYAL HOLDCO I INC. completed a disposition involving Century Casinos, Inc. and VICI Properties, L.P. for $260 million (closed 2023-07-25).

“On July 25, 2023, Golden Entertainment, Inc. (the “Company”) completed the sale of the Rocky Gap Casino Resort (“Rocky Gap”) to Century Casinos, Inc. (“Century”) and VICI Properties, L.P. (“VICI”), an affiliate of VICI Properties Inc., for aggregate cash consideration of $260 million, subject to adjustments, pursuant to the previously announced Equity Purchase Agreement with Century and VICI, and Real Estate Purchase Agreement with VICI (collectively, the “Purchase Agreements”).”

AEON Biopharma, Inc. underwent a change of control involving Old AEON Biopharma, Inc. (closed 2023-07-21).

“Pursuant to the terms and subject to the conditions set forth in the Business Combination Agreement, following the Special Meeting, on July 21, 2023 (the “Closing Date”), the Transactions were consummated (the “Closing”).”

Forian Inc. completed a disposition involving Vox Merger Sub, Inc. for approximately $5.9 million of cash proceeds, plus up to approximately $3.6 million in earnout payments (closed 2023-07-21).

“Medical Outcomes Research Analytics, LLC) held an equity interest merged with Vox Merger Sub, Inc. (the “Merger”). As a result of the Merger, Forian received approximately $5.9 million of cash proceeds in consideration of all of its equity interest in the customer. Forian may receive additional earnout payments in 2025 and 2026 in an aggregate amount of up to”

Spyre Therapeutics, Inc. completed a disposition involving Immedica Pharma AB for initial payment in cash of $15,000,000 due at Closing and up to $100,000,000 after the Closing (closed 2023-07-27).

“Subject to the terms and conditions of the Purchase Agreement, at the closing of the transactions (the “Closing”) contemplated by the Purchase Agreement (the “Asset Purchase”), Immedica purchased from the Company its assets related to its research, development and manufacturing program for pegzilarginase for the treatment of Arginase-1 Deficiency as well as other therapeutic, prophylactic, palliative and diagnostic uses (the “Program,” and any pharmaceutical product containing, incorporating or comprising pegzilarginase, the “Product”) for an initial payment in cash of $15,000,000 due at Closing and up to $100,000,000 after the Closing”

AIxCrypto Holdings, Inc. completed a disposition involving Chembio Diagnostics, Inc. for $5.1 million in cash (closed 2023-07-20).

“the consummation of the Transaction, the Subsidiary became a wholly-owned subsidiary of the Buyer. The aggregate net purchase price paid to the Company for the Shares was $5.1 million in cash, based on a base purchase price of $5.8 million, subject to certain post-closing adjustments, upward or downward, as applicable, for: (i) cash held by the Subsidiary as”

Lightstone Value Plus REIT II, Inc. completed a disposition involving Vista Acquisitions Inc. for $28.0 million (closed 2023-07-21).

“On July 21, 2023 and July 17, 2023, the Sellers completed the sale of the Hampton Inn & Suites - Miami and the Hampton Inn & Suites – Fort Lauderdale, respectively, to the Buyer for $28.0 million pursuant to the terms of the Florida Hotel Portfolio Agreement.”

LIVE VENTURES Inc completed an acquisition involving Precision Metal Works, Inc. for $25.0 million (closed 2023-07-20).

“(collectively, the “Sellers”), and, solely with respect to Section 5.09 thereof, Richard Stanley and John Locke. The aggregate purchase price for the Equity Interests was $25.0 million plus the Closing Cash, minus outstanding Indebtedness and minus unpaid Transaction Expenses (as such terms are defined in the Purchase Agreement), subject to certain adjustments”

CENTURY CASINOS INC /CO/ completed an acquisition involving Lakes Maryland Development, LLC for $56.1 million (closed 2023-07-25).

“On July 25, 2023 (the “Closing Date”), Century Casinos, Inc. (the “Company”) completed its previously announced acquisition (the “Acquisition”) of the operations of Evitts Resort, LLC dba Rocky Gap Casino Resort (“Rocky Gap”), located in Flintstone, Maryland from Lakes Maryland Development, LLC, a subsidiary of Golden Entertainment Inc. (“Lakes Maryland”), for an aggregate purchase price of approximately $56.1 million (subject to adjustment based on the Rocky Gap’s working capital and cash at closing), subject to the terms and conditions set forth in the Equity Purchase Agreement (the “Purchase Agreement”), dated as of August 24, 2022.”

Broad Street Realty, Inc. completed a disposition for $23.0 million in cash (closed 2023-06-30).

“on June 30, 2023, a subsidiary of the Company completed the sale of Spotswood Valley Square Shopping Center (together with Dekalb Plaza, the “Disposed Properties”), a retail shopping center located in Harrisonburg, Virginia with approximately 190,646 square feet of gross leasable area, for a purchase price of $23.0 million in cash (together with the Dekalb Disposition, the “Property Dispositions”).”

Broad Street Realty, Inc. completed a disposition for $23.1 million in cash (closed 2023-07-20).

“On July 20, 2023, a subsidiary of Broad Street Realty, Inc. (the “Company”) completed the sale of Dekalb Plaza, a retail shopping center located in Philadelphia, Pennsylvania with approximately 178,356 square feet of gross leasable area, for a purchase price of $23.1 million in cash (the “Dekalb Disposition”).”

PSQ Holdings, Inc. underwent a change of control involving PSQ Holdings, Inc. for Shares of Class A Common Stock and Class C Common Stock, plus earnout shares up to 3,000,000 shares based on trading price metrics (closed 2023-07-19).

“EPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 19, 2023 PSQ Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-40457 86-2062844 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S.”

ENZO BIOCHEM INC completed a disposition involving Laboratory Corporation of America Holdings for $113.25 million in cash (closed 2023-07-24).

“On July 24, 2023 (the “Closing Date”), pursuant to the terms of the Asset Purchase Agreement, as amended (the “Purchase Agreement”), by and among Enzo Biochem, Inc., a New York corporation (the “Company”), Enzo Clinical Labs, Inc., a New York corporation, and Laboratory Corporation of America Holdings, a Delaware corporation, the Company closed the sale of certain assets and assignment of certain liabilities of the Company’s clinical laboratory business (the “Asset Sale”) for $113.25 million in cash (the “Purchase Price”).”

SunPower Inc. underwent a change of control involving Legacy Complete Solaria, Inc. and The Solaria Corporation for $225,000,000 (closed 2023-07-18).

“of Complete Solaria Common Stock (the “ Aggregate Merger Consideration ”) issuable in connection with the consummation of the First Merger equals the quotient of: the sum of (x) $225,000,000 and (y) the product of (1) $10.00 and (2) the total number of shares of Complete Solaria Common Stock into which the Complete Solaria convertible notes would be convertible”

GreenLight Biosciences Holdings, PBC underwent a change of control involving SW ParentCo, Inc. and SW MergerCo, Inc. for $0.30 per share (closed 2023-07-24).

“stock, par value $0.0001 per share, of the Company (the “Company Common Stock”), other than certain excluded shares (including the Rollover Shares (as defined below)), for $0.30 per share, net to the seller in cash, without interest thereon (the “Offer Price”), and subject to any required withholding, upon the terms and subject to the conditions of the”

Greenrose Holding Co Inc. completed a disposition involving NewCo (DXR Parent/DXR Holdco) (closed 2023-07-21).

“On July 21, 2023, the parties completed the disposition of assets and closed the foreclosure transaction as to Theraplant and TH concurrently following satisfaction or waiver of the applicable closing conditions for each applicable closing, including receipt of the requisite regulatory approvals. At the applicable closing, each of Theraplant and TH assigned, transferred and conveyed its respective Transferred Collateral to NewCo in exchange for satisfaction in full and discharge of the applicable obligations and assumption by NewCo of certain liabilities.”

KBS Growth & Income REIT, Inc. completed a disposition involving a buyer affiliated with the Commonwealth Lender (closed 2023-07-18).

“On July 18, 2023, the Commonwealth Building was sold at public auction in a foreclosure sale to a buyer affiliated with the Commonwealth Lender and all interest in the Commonwealth Building was transferred to the buyer on that date.”

J.P. Morgan Real Estate Income Trust, Inc. completed an acquisition involving Old Louisville Savannah Propco, LLC for $74.7 million (closed 2023-07-17).

“As previously disclosed, on June 10, 2022, J.P. Morgan Real Estate Income Trust, Inc. (the “Company”) entered into an agreement with Old Louisville Savannah Propco, LLC (the “Seller”) to purchase a pre-leased truck transload facility located within the Savannah, GA metropolitan area (the “Truck Transload Facility”) for $74.7 million, exclusive of closing costs, which consisted of an initial purchase price of $73.2 million and an additional $1.5 million in tenant improvement costs. The Truck Transload Facility, constructed in 2023, is a Class A logistics facility encompassing 136,240 square feet with 134 doors situated on an approximately 60-acre site with approximately 50 net leasable acres. On July 17, 2023, the Company acquired the Truck Transload Facility from the Seller.”

CATALYST PHARMACEUTICALS, INC. completed an acquisition involving Santhera Pharmaceuticals Holdings AG for all-cash purchase payment of $75 million; strategic equity investment of approximately $15 million in Santhera ordinary shares; potential milestone payments and (closed 2023-07-19).

“Item 2.01 Completion of Acquisition or Disposition of Assets On July 19, 2023, Catalyst Pharmaceuticals, Inc. (the “ Company ”) completed its acquisition from Santhera Pharmaceuticals Holdings AG (“ Santhera ”) of an exclusive license for North America for vamorolone, a potential treatment for patients suffering with Duchenne Muscular Dystrophy (“ DMD ”). The license is for exclusive commercial rights in the U.S., Canada, and Mexico, as well as the right of first negotiation in Europe and Japan should Santhera pursue partnership opportunities. Additionally, the Company will hold North American rights for any future approved indications of vamorolone. As previously disclosed, the Company will make an all-cash purchase payment of $75 million to acquire the license pursuant to a License Agreement, dated June 19, 2023, by and between Santhera, its wholly owned subsidiary, Santhera Pharmaceuticals (Schweiz) AG, and the Company (the “ License Agreement ”). Simultaneously, pursuant to an Inve”

Longevity Health Holdings, Inc. underwent a change of control involving Alpha Healthcare Acquisition Corp. III (closed 2023-07-14).

“On July 14, 2023 (the “Closing Date”), Alpha Healthcare Acquisition Corp. III, a Delaware corporation and our predecessor company (“ALPA”), consummated the previously announced business combination (the “Business Combination”) pursuant to the terms of the Business Combination Agreement”

Berkshire Grey, Inc. underwent a change of control involving SoftBank Group Corp. for pursuant to the Merger Agreement (closed 2023-07-20).

“On July 20, 2023, pursuant to the Merger Agreement, Merger Sub merged with and into the Company (the “ Merger ”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.”

Charah Solutions, Inc. underwent a change of control involving Acquisition Parent 0423 Inc. for $6.00 per Share in cash (closed 2023-07-13).

“or (iii) Shares owned by holders who have properly exercised appraisal rights under Section 262 of the Delaware General Corporation Law) converted into the right to receive $6.00 per Share in cash, without interest (the “ Common Per Share Merger Consideration ”). In addition, at the Effective Time, each share of Series A Preferred Stock of the Company”

Extra Space Storage Inc. completed an acquisition involving Life Storage, Inc. for 0.895 shares of Extra Space Common Stock per share of Life Storage Common Stock (closed 2023-07-20).

“ace Merger Sub”), Eros OP Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Extra Space OP (“Extra Space OP Merger Sub” and, together with Extra Space, Extra Space OP and Extra Space Merger Sub, the “Extra Space Parties”), Life Storage, Inc., a Maryland corporation (“Life Storage”), and Life Storage LP, a Delaware limited partnership (“Life Storage OP” and, together with Life Storage, the “Life Storage Parties”), as amended on May 18, 2023 (the “Merger Agreement”).”

LIFE STORAGE LP underwent a change of control involving Extra Space Storage Inc. (closed 2023-07-20).

“This Current Report on Form 8-K is being filed in connection with the consummation on July 20, 2023 (the “Closing Date”) of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of April 2, 2023, by and among Extra Space Storage Inc., a Maryland corporation (“Extra Space”), Extra Space Storage LP, a Delaware limited partnership (“Extra Space OP”), Eros Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Extra Space (“Extra Space Merger Sub”), Eros OP Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Extra Space OP (“Extra Space OP Merger Sub” and, together with Extra Space, Extra Space OP and Extra Space Merger Sub, the “Extra Space Parties”), Life Storage, Inc., a Maryland corporation (the “Company”), and Life Storage LP, a Delaware limited partnership (“Life Storage OP” and, together with the Company, the “Life Storage Parties”), as amended on May 18, 2023 (the “Merger Agreement”).”

TESSCO TECHNOLOGIES INC underwent a change of control involving Alliance USAcqCo 2, Inc. and Alliance USAcqCo 2 Merger Sub, Inc. for $9.00 in cash (closed 2023-07-17).

“as provided in the Merger Agreement, each share of common stock of the Company, par value $0.01 (the “common stock”), then outstanding was converted into the right to receive $9.00 in cash, without interest (the “Merger Consideration”), other than those shares owned by Parent, the Company or any subsidiary of Parent or the Company (which were cancelled”

ALLIED HEALTHCARE PRODUCTS INC completed a disposition involving Allied Medical, LLC for $8,988,974 (closed 2023-07-12).

“On July 12, 2023, the Company and the Purchaser consummated each of the STL Sale and the NY Sale. The aggregate final purchase price of the STL Assets and NY Assets, after all adjustments and reimbursements contemplated in the STL Purchase Agreement and NY Purchase Agreement was $8,988,974.”

Atlanta Braves Holdings, Inc. completed a disposition involving Liberty Media Corporation (closed 2023-07-18).

“On July 18, 2023, at 5:00 p.m., New York City time (the “Effective Time”), Liberty Media Corporation (the “Liberty Media”) completed its previously announced split-off (the “Split-Off”) of its former wholly owned subsidiary Atlanta Braves Holdings, Inc. (“Company”).”

Liberty Media Corp completed a disposition involving Atlanta Braves Holdings, Inc. (closed 2023-07-18).

“On July 18, 2023 at 5:00 p.m., New York City time (the “Effective Time”), Liberty Media Corporation (the “Company”) completed its previously announced split-off (the “Split-Off”) of its former wholly owned subsidiary Atlanta Braves Holdings, Inc. (“Atlanta Braves Holdings”).”

Athenex, Inc. completed a disposition involving Sagent Pharmaceuticals for approximately $14.0 million (closed 2023-06-30).

“On June 23, 2023, Athenex Pharmaceutical Division, LLC (“APD”), one of the Debtors and a subsidiary of the Company, entered into an asset purchase agreement (“APD Agreement”) with Sagent Pharmaceuticals (“Sagent”), pursuant to which Sagent agreed to purchase the assets used in APD’s business, excluding its cash, cash equivalents and accounts receivable, among other things (the “APD Assets”), subject to the terms and conditions contained in the APD Agreement. Sagent was the highest bidder at Auction and paid a cash purchase price of approximately $14.0 million for the APD Assets at closing. The sale of the APD Assets was approved by the Bankruptcy Court on June 27, 2023 and closed on June 30, 2023.”

Athenex, Inc. completed a disposition involving Health Hope Pharma Limited for $2.5 million (closed 2023-07-07).

“On June 29, 2023, C-Mer assigned its rights and obligations under the Orascovery Agreement to Health Hope Pharma Limited (“Orascovery Buyer”). Under the Orascovery Agreement, the Orascovery Buyer paid a cash purchase price of $2.5 million for the Orascovery Assets at closing, with a milestone payment of $5.0 million to be promptly paid to Athenex R&D LLC after worldwide net sales of oral paclitaxel have reached $10.0 million. The sale of the Orascovery Assets was approved by the Bankruptcy Court on June 21, 2023 and closed on July 7, 2023.”

Cyber App Solutions Corp. completed an acquisition involving Proton Green, LLC and its members for issuance of approximately 68 million shares of common stock, representing approximately 94.4% of the issued and outstanding shares of common stock of the Compan (closed 2023-07-17).

“interests of Proton Green held by the Proton Green Members for shares of common stock of the Company. At the Closing Date, the Company issued approximately sixty-eight million (68,000,000) newly issued shares s of common stock to the Proton Green Members, representing approximately 94.4% of the issued and outstanding shares of common stock of the Company following”

QualTek Services Inc. underwent a change of control (closed 2023-07-14).

“On the Effective Date, pursuant to the Plan, all existing equity interests of the Company issued and outstanding immediately prior to the Effective Date, and any rights of any holder in respect thereof, were deemed cancelled, released and extinguished and are now of no further force or effect. As described in Item 3.02, on the Effective Date, pursuant to the Plan, the Reorganized Company issued the New Equity Interests and the New Warrants.”

EVENTIKO INC. underwent a change of control involving Greentop International Holdings Limited (closed 2023-07-11).

“Effective July 11, 2023, Miklos Pal Auer, the previous majority shareholder of Eventiko, Inc. (the “Company”), entered into a stock purchase agreement for the sale of 3,000,000 shares of Common Stock of the Company to Greentop International Holdings Limited, a company organzined under the laws of the Czech Republic.”

MALVERN BANCORP, INC. underwent a change of control involving First Bank for $7.80 in cash and 0.7733 shares of First Bank common stock (closed 2023-07-17).

“to the terms of the Merger Agreement, at the effective time of the Merger (the “ Effective Time ”), each share of Malvern common stock was converted into the right to receive $7.80 in cash and 0.7733 shares of First Bank common stock, with cash paid in lieu of fractional shares pursuant to the Merger Agreement. At the Effective Time, each outstanding Malvern”

Bravo Multinational Inc. completed an acquisition involving Recombinant Productions Inc. (closed 2023-07-13).

“On July 13, 2023, this transaction closed in accordance with terms of the Stock Purchase Agreement previously filed.”

Yinfu Gold Corp. underwent a change of control involving Bo Shaorong for Total consideration of $168,000 (issuance of 28,400,000 shares at $0.001 per share for $28,000; purchase of 50,000,000 shares at $0.002 per share for $100,000; (closed 2023-03-09).

“On February 22, 2023, the Company issued 28,400,000 shares of its common stock at a private placement of US $0.001 per share for proceeds of $28,000.00 to Mr. Bo Shaorong. On March 09, 2023, Mr. Bo Shaorong purchased 50,000,000 shares common stock from shareholder of Mr.Chen Qiang at US $0.002 per share. On March 09, 2023, Mr. Bo Shaorong purchased 20,000,000 shares common stock from shareholder LAI Haiying at US $0.002 per share. By execution of those transactions, Mr. Bo Shaorong holds 98,400,000,or 80.67% shares of the 121,983,993 shares of the Company’s outstanding common stock. Which means Mr. Bo Shaorong takes control of the Company.”

BNB PLUS CORP. completed an acquisition involving Spindle Biotech Inc. for cash of $625,000 and 750,000 restricted shares of common stock, plus potential earn-out (closed 2023-07-12).

“the transactions contemplated by the Purchase Agreement, the Purchaser agreed to pay or issue to the Sellers, as applicable, on a pro rata basis: (i) a cash purchase price of $625,000, as adjusted for debt of Spindle as of the closing date and expenses related to the transaction, which was paid to the Sellers on the Closing Date; (ii) 750,000 restricted shares”

BGO Industrial Real Estate Income Trust, Inc. completed an acquisition involving Sun Life (U.S.) HoldCo 2020, Inc. for $130 million (closed 2023-07-07).

“13,000,000 Class E units of the Operating Partnership at a price per unit equal to $10.00 (the “Seed JV Acquisition”). The purchase price of the Seed Joint Venture is equal to $130 million, which represents the aggregate capital contributions made by Sun Life in respect of the Seed Joint Venture. As of March 31, 2023, the estimated gross asset value of the Seed”

Gold Flora Corp. underwent a change of control involving TPCO Holding Corp. (closed 2023-07-07).

“On July 7, 2023, TPCO and Gold Flora, LLC, a California limited liability company (“Gold Flora”), completed a previously announced business combination pursuant to the Business Combination Agreement.”

SMG Industries Inc. completed an acquisition involving Bryan S. Barnhart, Timothy W. Barnhart, and Timothy W. Barnhart as Trustee of the Timothy W. Barnhart 2017 Irrevocable Trust for (i) $26.0 million in cash, subject to customary net working capital, cash, indebtedness, and transaction expense adjustments, less $3.0 million for Indemnificat (closed 2023-07-07).

“for Legend, which became a direct and wholly owned subsidiary of Skyline Holding. The Company paid a purchase price (the “Purchase Price”) for the Acquisition consisting of (i) $26.0 million in cash, subject to customary net working capital, cash, indebtedness, and transaction expense adjustments, less (A) $3.0 million for the Indemnification Escrow Amount (as”

IVERIC bio, Inc. underwent a change of control involving Astellas US Holding, Inc. for $40.00 per Share in cash (closed 2023-07-11).

“of common stock, par value $0.001 per share, of IVERIC (a “ Share ”) outstanding immediately prior to the effective time of the Merger was converted into the right to receive $40.00 per Share in cash, without interest (the “ Per Share Merger Consideration ”) less any applicable withholding taxes (except for any Shares owned by (1) IVERIC, (2) Parent or Merger”

BORGWARNER INC completed a disposition involving PHINIA Inc. for distribution of 100% of the outstanding shares of common stock of PHINIA Inc. to holders of record of common stock of the Company on a pro rata basis; each hold (closed 2023-07-03).

“On July 3, 2023 (the “Distribution Date”), at 5:00 p.m. Eastern Daylight time, BorgWarner Inc. (the “Company”, “we,” “us,” or “our”) completed the previously announced separation of our Fuel Systems and Aftermarket businesses by way of a distribution of 100% of the outstanding shares of common stock of PHINIA Inc. (“PHINIA”) to holders of record of common stock of the Company on a pro rata basis (the “Spin-Off”).”

HECLA MINING CO/DE/ completed an acquisition involving ATAC Resources Ltd. for approximately US$18.7 million (closed 2023-07-07).

“Agreement (“Agreement”). Under the terms of the Agreement, Hecla’s subsidiary acquired all the outstanding common shares of ATAC for total consideration of approximately US$18.7 million in the form of 3,676,904 shares of Hecla common stock issued to ATAC shareholders based on the share exchange ratio of 0.0166 of Hecla share for each ATAC common share. As part”